Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors
Pamela A. Lochhead, Julie A. Tucker, Natalie J. Tatum and 8 more
Nature Communications · 2020
doi:10.1038/s41467-020-15031-3 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Selective ERK5 inhibitors target ERK5 kinase activity, but they do not phenocopy the effects of ERK5 genetic depletion. Here, the authors demonstrate that the direct interaction of these inhibitors to ERK5 kinase domain induces conformational changes that promote ERK5 nuclear translocation and transcriptional activities.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.